enGene (ENGN) announced the appointment of Joan Connolly as CTO and member of the corporate leadership team. In addition, enGene co-founder and former CTO, Anthony Cheung, will transition to the role of chief scientific officer, or CTO, succeeding James Sullivan. Connolly’s career spans more than 30 years, with experience across CMC development for large and small molecules, manufacturing management, regulatory filings, and product commercialization, as well as supply chain, logistics and sourcing, and procurement. In her most recent role, Connolly served as CTO of Albireo Pharma. Cheung is a co-founder of enGene and has served in various capacities since the company’s inception.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENGN:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue